Abstract
Background: Breast cancer is the most common cancer in Australian females, with one in eight women estimated to be diagnosed over their lifetime. Persistent pain is becoming increasingly recognised as a significant clinical problem following treatment for breast cancer, with a reported prevalence of between 13 and 51%. Despite increasing recognition of the clinical significance of persistent pain following breast cancer treatment, clinical guidelines for the assessment and treatment of pain are lacking. Further, data on risk factors for persistent pain are variable.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
